CFR 21(PTS600-799) : 0
Superseded
A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.
View Superseded by
FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 600-799
21-11-2019
Part 600 - Biological products: general
Part 601 - Licensing
Part 606 - Current good manufacturing practice for blood and blood
components
Part 607 - Establishment registration and product listing for
manufacturers of human blood and blood products
Part 610 - General biological products standards
Part 630 - General requirements for blood, blood components, and
blood derivatives
Part 640 - Additional standards for human blood and blood products
Part 660 - Additional standards for diagnostic substances for
laboratory tests
Part 680 - Additional standards for miscellaneous products
Part 700 - General
Part 701 - Cosmetic labeling
Part 710 - Voluntary registration of cosmetic product establishments
Part 720 - Voluntary filing of cosmetic product ingredient composition
statements
Part 740 - Cosmetic product warning statements
Part 741-799 - [Reserved]
DocumentType |
Standard
|
PublisherName |
Code of Federal Regulations
|
Status |
Superseded
|
SupersededBy |
DI-TCSP-82040 Base Document:2016 | RESEARCH AND DEVELOPMENT OF MEDICAL PRODUCTS REGULATED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) |
CGSB 106.5 : 95 CORR 1 95 | BLOOD GROUPING AND ANTI-HUMAN GLOBULIN REAGENTS |
ASTM F 2900 : 2011 | Standard Guide for Characterization of Hydrogels used in Regenerative Medicine (Withdrawn 2020) |
ANSI/AAMI/IEC 60601-1-2:2014 | MEDICAL ELECTRICAL EQUIPMENT - PART 1-2: GENERAL REQUIREMENTS FOR BASIC SAFETY AND ESSENTIAL PERFORMANCE - COLLATERAL STANDARD: ELECTROMAGNETIC DISTURBANCES - REQUIREMENTS AND TESTS |
ASTM F 2529 : 2013 | Standard Guide for <emph type="bdit">in vivo</emph> Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM) |
ASTM F 2027 : 2016 : REDLINE | Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products |
ASTM F 2721 : 2009 : R2014 | Standard Guide for Pre-clinical <emph type="bdit">in vivo</emph> Evaluation in Critical Size Segmental Bone Defects |
ASTM F 2884 : 2012 | Standard Guide for Pre-clinical <emph type="bdit">in vivo</emph> Evaluation of Spinal Fusion (Withdrawn 2021) |
ASTM F 2386 : 2004 | Standard Guide for Preservation of Tissue Engineered Medical Products (TEMPs) (Withdrawn 2013) |
ASTM F 2383 : 2011 : REDLINE | Standard Guide for Assessment of Adventitious Agents in Tissue Engineered Medical Products (TEMPs) |
ISO/TR 18112:2006 | Clinical laboratory testing and in vitro diagnostic test systems In vitro diagnostic medical devices for professional use Summary of regulatory requirements for information supplied by the manufacturer |
AAMI TIR48 : 2015 | QUALITY MANAGEMENT SYSTEM (QMS) RECOMMENDATIONS ON THE APPLICATION OF THE U.S. FDAS CGMP FINAL RULE ON COMBINATION PRODUCTS |
NFPA 921 : 2017 | GUIDE FOR FIRE AND EXPLOSION INVESTIGATIONS |
ASTM F 2903 : 2011 | Standard Guide for Tissue Engineered Medical Products (TEMPs) for Reinforcement of Tendon and Ligament Surgical Repair (Withdrawn 2020) |
ASTM F 963 : 2017 : REDLINE | Standard Consumer Safety Specification for Toy Safety |
ASTM F 2721 : 2009 | Standard Guide for Pre-clinical <span class="bdit">in vivo</span> Evaluation in Critical Size Segmental Bone Defects |
IEC 60601-1-2:2007 | Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.